The COVID-19 pandemic has brought renewed attention to the topic of challenging drug patents in the interest of public health. Pharmaceutical companies have already begun to patent existing medicines for the treatment and prevention of SARS-CoV-2, ...
Make this part of your paper trail
Save this paper to a shelf, write a review, and keep your own notes.